Ledipasvir

ATC — · 8 markets · 15 records

Ledipasvir 8 markets · 15 records Forms

US 5 records · 4 strengths

90 mgtabletHarvoni+1__no_trade__ also in GB·CA·ES
45 mgtabletHarvoni also in GB
45 mgpelletHarvoni
33.75 mgpelletHarvoni

GB 4 records · 4 strengths

90 mgtabletHarvoni also in US·CA·ES
45 mgtabletHarvoni also in US
45 mgpowderHarvoni 33.75mg/150mg granules sachets
33.75 mgpowderHarvoni 33.75mg/150mg granules sachets

CA 1 records · 1 strengths

90 mgtabletHarvoni also in US·GB·ES

AU 1 records · 1 strengths

Records without a stated strength · 1 Harvoni

ES 1 records · 1 strengths

90 mgtabletHarvoni also in US·GB·CA

TW 1 records · 1 strengths

Records without a stated strength · 1 Harvoni、夏奉寧膜衣錠

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Harvoni

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.